The proposal, first announced by the Biden administration, was developed to improve patient data security. Those opposed argue that it would significantly increase costs and create a logistical nightmare for hospitals and health systems throughout the country.
Cardiologists often use the word “stable” when describing a heart failure patient who is recovering or showing signs of improvement. That word, however, could be giving patients a false sense of security—and it could even do harm to their long-term health.
Pediatric electrophysiology is an invaluable part of any healthcare system, and its importance is only growing as technologies continue to evolve. We spoke to Nicholas Von Bergen, MD, to learn more about where the specialty is headed in the years ahead.
A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.
According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients.
Hemostemix believes its new cell therapy platform can help treat peripheral artery disease, congestive heart failure, cardiomyopathy and other serious medical conditions. The company plans on scooping up multiple practices to conduct additional research and increase the use of its platform.
There is a risk of certain pericardial patches not being as strong or durable as needed. Customers are urged to identify, quarantine and replace these devices.
It is still unclear which imaging exams President Donald Trump underwent to evaluate his cardiovascular health. The White House shared a memo Monday as an attempt to put this topic to bed—but questions remain.
Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.
One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.
Researchers recently used advanced 4D flow MRI to track blood in a pulsating artificial heart, revealing dynamics that closely mirror those of a healthy human organ.
Congress needs to act soon to extend telemedicine services that were greatly expanded under COVID provisions, or they will expire by October. Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains concerns raised by doctors and lawmakers.
![The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.](/sites/default/files/styles/stack_views/public/2024-12/screenshot_2024-12-02_at_11.07.21_am.png.webp?itok=WCWcIaTj)
